What is VSTM (VSTM) stock price today?

VSTM (VSTM) is currently trading at $6.08, up 0.5% today.

What is VSTM P/E ratio?

VSTM's P/E ratio is -1.38. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is VSTM return on equity (ROE)?

VSTM's return on equity (ROE) is -366.67%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is VSTM's market cap?

VSTM has a market capitalization of $534.27M.

NASDAQ · Biotechnology

VSTM (VSTM) Stock

$6.08 +0.50% NASDAQ: VSTM Healthcare

Valuation

Metric	Value
Price	$6.08
Market Cap	$534.27M
P/E Ratio	-1.38
P/B Ratio	5.05
P/S Ratio	5.91
EPS (TTM)	$-3.02
52-Week High	$11.25
52-Week Low	$3.45
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-366.67%
ROA	-84.96%
ROCE	-298.25%
Gross Margin	-548.39%
Operating Margin	-548.39%
Net Margin	-3.91%
Debt/Equity	1.05
Current Ratio	3.10

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$2.0M	$3.0M	$0	$10.0M	$31.0M
Operating Profit	$-61.0M	$-73.0M	$-92.0M	$-115.0M	$-170.0M
Net Profit	$-71.0M	$-74.0M	$-87.0M	$-131.0M	$-209.0M
EPS	$-4.92	$-4.57	$-3.96	$-3.66	$-3.02
Op Margin	-2991.2%	-2809.6%	—	-1149.6%	-550.3%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$109.0M	$95.0M	$150.0M	$102.0M	$246.0M
Total Liabilities	$21.0M	$48.0M	$92.0M	$130.0M	$189.0M
Cash	$21.0M	$75.0M	$78.0M	$89.0M	$205.0M
Borrowings	$3.0M	$27.0M	$42.0M	$42.0M	$77.0M

Latest News

Verastem Oncology Doses First Patient in TARGET-D 202 Phase 2 Registration-Directed Trial of VS-7375 for KRAS G12D-Mutated Advanced Non-Small Cell Lung Cancer Business Wire · Jul 22, 2026 RBC Capital Reaffirms Outperform Rating For Verastem (VSTM) Insider Monkey · Jul 15, 2026 Verastem (VSTM) Surges 6.3%: Is This an Indication of Further Gains? Zacks · Jul 10, 2026 RBC Capital Adjusts Verastem Price Target to $14 From $15, Maintains Outperform Rating MT Newswires · Jul 7, 2026 Here’s What RBC Capital Has to Say About Verastem (VSTM) Insider Monkey · Jul 3, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-54.0M	$-64.0M	$-86.0M	$-105.0M	$-138.0M
Investing Cash Flow	$0	$66.0M	$-44.0M	$60.0M	$-10.0M
Financing Cash Flow	$0	$0	$0	$41.0M	$0
Net Cash Flow	$-47.0M	$54.0M	$3.0M	$10.0M	$116.0M
Free Cash Flow	$-54.0M	$-64.0M	$-86.0M	$-105.0M	$-138.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-51.48%
Quick Ratio	3.00
Interest Coverage	-170.00
Return 1Y	15.51%
Return 3Y	-36.02%
Return 5Y	-86.32%

Ownership

Insiders Held0.93%

Institutions Held98.34%

Institutions Float Held99.26%

Institutional Holder	Shares	Report Date
RTW Investments LP	6,576,306	2026-03-31
Blackrock Inc.	6,194,925	2026-03-31
Deep Track Capital, Lp	5,740,850	2026-03-31
Armistice Capital, LLC	4,592,000	2026-03-31
Nantahala Capital Management, LLC	3,584,820	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ABSI	$7.13	-5.69%	-11.32	$1.21B	0.00%
CRVS	$13.31	+3.02%	-23.00	$1.12B	0.00%
FDMT	$10.09	-0.88%	-3.47	$527.47M	0.00%
GOSSGossamer Bio, Inc.	$0.19	+38.24%	-0.17	$44.10M	0.00%
KALV	$27.00	+0.00%	-8.28	$1.44B	0.00%

About VSTM

VSTM is led by CEO Daniel W. Paterson, employs 78 people, headquartered in US, publicly traded since 2012.

VSTM stock trades at $6.08 with a market capitalization of $534.27M. The stock is valued at a price-to-earnings (P/E) ratio of -1.38, price-to-book of 5.05, price-to-sales of 5.91. Over the past 52 weeks the stock has ranged between $3.45 and $11.25, and currently trades 46.0% below its 52-week high.

On profitability, VSTM generates a return on equity (ROE) of -366.67%, return on capital employed of -298.25%, an operating margin of -548.39%, a net profit margin of -3.91%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides